Join the 'Benicar HCT' group to help and get support from people like you. How it works
Benicar HCT Blog
| Tweet |
U.S. Task Force Issues Blood Pressure Guidelines
Posted 12 days ago by Drugs.com
TUESDAY, May 15 – "Team-based care" should be used to improve patients' blood pressure control, the U.S. Task Force on Community Preventive Services recommended on Tuesday. The recommendation is based on a review of 77 studies that showed improvements in patients' control of blood pressure when they received care from a team of health professionals – a primary care doctor supported by a pharmacist, nurse, dietitian, social worker, or community health worker – rather than a primary care doctor alone. The task force found that team-based care increased the percentage of patients with controlled blood pressure, led to a decrease in both systolic (top number) and diastolic (bottom number) blood pressure, and improved results in patients with diabetes and elevated levels of blood fats. Team members assist primary care doctors by providing support and sharing responsibility for high blood ... Read more
Related support groups: High Blood Pressure, Lisinopril, Hypertension, Metoprolol, Atenolol, Diovan, Benicar, Amlodipine, Propranolol, Bystolic, Norvasc, Losartan, Verapamil, Diltiazem, Micardis
Accidental Medication Poisonings in Kids on the Rise
Posted 16 Sep 2011 by Drugs.com
FRIDAY, Sept. 16 – Despite ongoing prevention efforts, a growing number of young children are being accidentally poisoned with medications, according to new research. The study, which was based on data reported to the American Association of Poison Control Centers between 2001 and 2008, found that medication poisoning among children aged 5 and under increased by 22 percent, although the number of children in the United States in this age group rose by only 8 percent during the study period. "The problem of pediatric poisoning in the U.S. is getting worse, not better," Dr. Randall Bond, of Cincinnati Children's Hospital Medical Center, said in a hospital news release. In conducting the study, which is scheduled for publication in the Journal of Pediatrics, the researchers reviewed information on over 544,000 children who landed in the emergency department due to medication poisoning ... Read more
Related support groups: Suboxone, Xanax, Methadone, Oxycodone, Percocet, OxyContin, Hydrocodone, Vicodin, Morphine, Norco, Fentanyl, Klonopin, Lortab, Lisinopril, Subutex
FDA Medwatch Alert: Angiotensin Receptor Blockers (ARBs): Drug Safety Communication - Drug Safety Review Completed
Posted 4 Jun 2011 by Drugs.com
[UPDATED 06/02/2011] FDA’s meta-analysis of 31 randomized controlled trials comparing ARBs to other treatment found no evidence of an increased risk of incident (new) cancer, cancer-related death, breast cancer, lung cancer, or prostate cancer in patients receiving ARBs. [Posted 07/15/2010] ISSUE: A recently published study - a meta-analysis combining cancer-related findings from several clinical trials - suggested use of ARBs may be associated with a small increased risk of cancer. BACKGROUND: ARBs are used in patients with high blood pressure and other conditions. Brand names include Atacand, Avapro, Benicar, Cozaar, Diovan, Micardis, and Teveten. The meta-analysis included data from over 60,000 patients in several long-term, randomized, controlled clinical trials evaluating ARBs for which adverse events related to cancer were captured during the study. The mean duration of fo ... Read more
Related support groups: Diovan, Benicar, Losartan, Micardis, Cozaar, Azor, Avapro, Benicar HCT, Diovan HCT, Hyzaar, Exforge, Atacand, Avalide, Valsartan, Telmisartan
FDA Medwatch Alert: Benicar (olmesartan): Ongoing Safety Review
Posted 16 Apr 2011 by Drugs.com
[UPDATED 04/14/2011] After reviewing the results of the ROADMAP and ORIENT trials, FDA has determined that the benefits of Benicar continue to outweigh its potential risks when used for the treatment of patients with high blood pressure according to the drug label. Benicar is not recommended as a treatment to delay or prevent protein in the urine (microalbuminuria) in diabetic patients. Patients should consult their healthcare professional if they have any questions or concerns about taking Benicar. Daiichi Sankyo, the makers of Benicar, have agreed to work with the FDA to perform additional studies, as well as conduct additional analyses of completed clinical studies, to obtain more complete information about the cardiovascular risks or benefits of Benicar in various clinical settings. FDA will update the public when new information is available. [Posted 06/11/2010] ISSUE: FDA is ... Read more
Related support groups: Benicar, Azor, Benicar HCT, Olmesartan, Tribenzor, Hydrochlorothiazide/Olmesartan, Amlodipine/hydrochlorothiazide/olmesartan, Amlodipine/Olmesartan
Blood Pressure Drug Delays Kidney Disease in Diabetics
Posted 10 Mar 2011 by Drugs.com
WEDNESDAY, March 9 – A drug normally used to lower blood pressure may also help protect the kidneys of people with type 2 diabetes, researchers are reporting with a caveat. In a new study, an international team of researchers found that the drug pressure-reducing medication olmesartan, brand name Benicar, could increase the time before any kidney problems were evident by 23 percent. The study measured the possibility of kidney function problems by measuring the amount of albumin secreted in the urine (microalbuminuria). "Olmesartan was associated with a delayed onset of microalbuminuria, even though blood-pressure control in both groups was excellent according to current standards," wrote the study's authors in a report published in the March 10 issue of the New England Journal of Medicine, "Microalbuminuria is a marker for renal disease, and preventing renal disease is important for ... Read more
Related support groups: Diabetes, Type 2, Benicar, Azor, Benicar HCT, Olmesartan, Tribenzor, Amlodipine/Olmesartan, Hydrochlorothiazide/Olmesartan, Amlodipine/hydrochlorothiazide/olmesartan